Background As studies on gastrointestinal neuroendocrine carcinoma (WHO G3) (GI-NEC)
are limited, we reviewed clinical data to identify predictive and prognostic markers for …

Background Concurrent chemoradiotherapy is standard treatment for limited stage small-cell
lung cancer (SCLC). Twice-daily thoracic radiotherapy of 45 Gy in 30 fractions is …

Background Segmentation of neuroendocrine neoplasms (NENs) in [ 64 Cu]Cu-DOTATATE
positron emission tomography makes it possible to extract quantitative measures useable …

Introduction Treatment with a topoisomerase I inhibitor in combination with a platinum
results in superior or equal survival compared with etoposide-based treatment in extensive …

8512 Background: Concurrent chemotherapy and TRT is standard treatment of LS SCLC. BID
TRT of 45 Gy/30 fractions is the most recommended schedule. Trials report 5-year survival …

The American Society of Clinical Oncology recommends that granulo cyte colony stimulating
factors (G-CSF) should be avoided in patients receiving concomitant chemoradiotherapy, …

Introduction: Neuroendocrine neoplasms (NEN) of the appendix occur with an incidence of
0.15–0.6/100,000/year Aim (s): To characterize a cohort of 251 appendiceal NEN and to …

… Material preparation, data collection and analysis were performed by Annika Marie Ørting,
Malene Martini Clausen, and Seppo W. Langer. The first draft of the manuscript was written by …

An increase in the Ki‐67 index in neuroendocrine neoplasms over time in relation to prognosis
has scarcely been investigated. We aimed to assess whether the Ki‐67 index changed …

… Langer. The first draft of the manuscript was written by Morten Mau-Sørensen, Jonas
Gerner-Rasmussen, and Seppo W. Langer, and all authors commented on previous versions of the …